Cargando…

Galectin-3 Inhibition in COVID-19

Detalles Bibliográficos
Autores principales:	Reddy, Kiran, Nichol, Alistair, McAuley, Daniel F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893318/ https://www.ncbi.nlm.nih.gov/pubmed/36154818 http://dx.doi.org/10.1164/rccm.202209-1758ED

Ejemplares similares

COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?
por: Reddy, Kiran, et al.
Publicado: (2021)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

A reply to analysis of static parameters in retrospective studies: limitations and interpretation
por: McGuigan, Peter J., et al.
Publicado: (2023)

Immunopathology of galectin-3: an increasingly promising target in COVID-19
por: Caniglia, John L., et al.
Publicado: (2020)

Gaining muscle mass in COPD: a work in progress
por: McAuley, Hamish J.C., et al.
Publicado: (2023)

A potential role for Galectin-3 inhibitors in the treatment of COVID-19
por: Caniglia, John L., et al.
Publicado: (2020)

Galectin-3 as an Arrhythmogenic Predictive Marker for Heart Failure
por: Inoue, Keiko, et al.
Publicado: (2022)

The Impact of COVID-19 on Well-Being: Welsh Children’s Perspectives
por: Hampton, Jennifer, et al.
Publicado: (2023)

Delirium in COVID-19: can we make the unknowns knowns?
por: Wilcox, M. Elizabeth, et al.
Publicado: (2021)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Galectin-3 in Heart Failure: More Answers or More Questions?
por: Ahmad, Tariq, et al.
Publicado: (2012)

Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19
por: Aminpour, Maral, et al.
Publicado: (2021)

Non-invasive respiratory support strategies in COVID-19
por: Gorman, Ellen, et al.
Publicado: (2021)

Galectin-3 Inhibits Galectin-8/Parkin-Mediated Ubiquitination of Group A Streptococcus
por: Cheng, Yi-Lin, et al.
Publicado: (2017)

Major differences in ICU admissions during the first and second COVID-19 wave in Germany
por: Karagiannidis, Christian, et al.
Publicado: (2021)

Increased Levels of Galectin-3 in Critical COVID-19
por: Nikitopoulou, Ioanna, et al.
Publicado: (2023)

Apples and oranges: international comparisons of COVID-19 observational studies in ICUs
por: Millar, Jonathan E, et al.
Publicado: (2020)

Galectin-1 in myelin repair
por: Rinaldi, Mariana, et al.
Publicado: (2016)

COVID-19: consider cytokine storm syndromes and immunosuppression
por: Mehta, Puja, et al.
Publicado: (2020)

COVID‐19: Infection prevention and control guidance for all ultrasound practitioners
por: Basseal, Jocelyne M., et al.
Publicado: (2020)

Cell Biology of Galectins: Novel Aspects and Emerging Challenges
por: Timoshenko, Alexander V.
Publicado: (2022)

Galectins in Cancer and Translational Medicine: From Bench to Bedside
por: Bartolazzi, Armando
Publicado: (2018)

Galectin-3 as an important prognostic marker for COVID-19 severity
por: Gajovic, Nevena, et al.
Publicado: (2023)

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19
por: Puccini, Marianna, et al.
Publicado: (2023)

Galectin-1 as an oncotarget in gliomas and melanomas
por: Lefranc, Florence, et al.
Publicado: (2011)

Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
por: Lau, Emily S., et al.
Publicado: (2021)

Galectin-3 and galectin-3 binding protein in rheumatoid arthritis
por: Ohshima, S, et al.
Publicado: (2003)

Galectin-3 Negatively Regulates Hippocampus-Dependent Memory Formation through Inhibition of Integrin Signaling and Galectin-3 Phosphorylation
por: Chen, Yan-Chu, et al.
Publicado: (2017)

FEASIBILITY AND ACCEPTABILITY OF A HYBRID AEROBIC EXERCISE PROGRAM FOR OLDER ADULTS DURING THE COVID-19 PANDEMIC
por: Erlenbach, Emily, et al.
Publicado: (2022)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

Practical strategies for delivering airway training in the COVID-19 era
por: Hickman, John, et al.
Publicado: (2021)

30-day mortality following trauma and orthopaedic surgery during the peak of the COVID-19 pandemic: a multicentre regional analysis of 484 patients
por: Karayiannis, Paul N., et al.
Publicado: (2020)

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)
por: Hutter, Stefan, et al.
Publicado: (2016)

Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19
por: Özcan, Sevgi, et al.
Publicado: (2022)

An analysis of Covid-19 deaths and equality in Northern Ireland.
por: Hughes, John, et al.
Publicado: (2022)

Acute Respiratory Distress Syndrome
por: Adams, Claire E., et al.
Publicado: (2022)

Acute respiratory distress syndrome
por: Sweeney, Rob Mac, et al.
Publicado: (2016)

485. Title: The Porous Boundaries Between Communities and Correctional Facilities: The Introduction of a Medical Recovery Site Resulting in Reduced COVID-19 Household Transmission Tied to Recently Incarcerated Individuals
por: Pocock, Katherine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fsth6l45doijcu5vp85l3h0a6i